Search Results for “EC” – Page 581 – media

Addex, Indivior Forge $335M Addiction Disorder Tie-Up

Indivior announced that Indivior UK Limited has entered into a strategic collaboration with Addex Pharma S.A., a wholly-owned subsidiary of Addex Therapeutics (SIX: ADXN) ("Addex"), in the field of GABAB positive allosteric modulators (PAMs). GABAB PAMs have demonstrated preclinical efficacy and tolerability in animal models for alcohol use disorder (AUD) and cocaine use disorder (CUD)1,2.
- Source: Biospace
- 416
- January 8, 2018
AUD CUD GABAB PAM Market Views
Pfizer, Arvinas Forge $830M Protein Degradation R&D Deal

Two months after expanding a licensing deal with Genentech, privately-held Arvinas LLC struck another lucrative deal with a major pharmaceutical company. Connecticut-based Arvinas inked a deal with Pfizer worth up to $830 million to develop small molecules that can degrade proteins.
- Source: Biospace
- 521
- January 8, 2018
Genentech Pfizer pharmaceutical company PROTAC small molecule therapeutics
Surgery death rates in Africa are twice global average

The risk of dying from scheduled surgery in Africa is more than double the global average, researchers said on Wednesday, in a study shedding light on one of the continent's biggest but poorly investigated healthcare problems.
- Source: msn
- 602
- January 8, 2018
healthcare Researches Surgery death
Next-generation medical scanning

Researchers have developed a new way to magnetise molecules found naturally in the human body, paving the way for a new generation of low-cost magnetic resonance imaging (MRI) technology that would transform our ability to diagnose and treat diseases including cancer, diabetes and dementia.
- Source: ScienceDaily
- 519
- January 8, 2018
medical device MRI Researches
Pfizer, Novartis and more post price hikes

It's not just specialty drugmakers raising prices in recent days. Big Pharma has pushed through a spate of increases, and while all of them are sub-10%—the cap some companies have adopted—some of them will cost payers and consumers plenty.
- Source: fiercepharma
- 464
- January 5, 2018
drugmaker Market Views price increase
Innovative device helpful in hip replacement surgery

An innovative device for measuring the change of the femur position during hip replacement surgery has been built by scientists from Lodz University of Technology. Its use shortens the time of surgery and gives better chance that patients after surgery will not have problems with walking.
- Source: Science in Poland
- 852
- January 5, 2018
medical device medical device products Researches surgery
The Quantified Self, Our Wearable Future

Smaller, smarter, more efficient and prettier…. Wearables are becoming increasingly more popular. Where first only sport fanatics and early tech adopters were interested, we now see that the high tech wearable devices become more common and accepted.
- Source: Digital Salutem
- 1,215
- January 5, 2018
healthcare technology Market Views medical device mHealth wearables
4 Ways to Reduce EHR Use-Related Patient Safety Threats Widespread EHR use increases the potential for patient safety risks to occur, so providers must prepare accordingly.

A study released in October 2017 found EHR (electronic health records) use has been listed as a contributing factor to patient injury at an increased rate over the past decade. Poorly-designed EHR systems combined with human error have resulted in patient safety problems in an increasing number of malpractice claims from 2007-2016.
- Source: Xtelligent Media
- 498
- January 5, 2018
EHR health IT healthcare technology Policy
People Who Sleep Less Than 8 Hours a Night More Likely to Suffer Anxiety and Depression

Binghampton University researchers report sleeping less than 8 hours a night can result in negative, repetitive thoughts associated with anxiety and depression.
- Source: neurosciencenews
- 418
- January 5, 2018
anxiety Depression Researches Sleep deprivation
US awards Novartis’ Kisqali ‘Breakthrough’ status

Novartis’ CDK4/6 inhibitor Kisqali has picked up Breakthrough status in the US as an initial endocrine-based treatment in certain patients with breast cancer.
- Source: pharmatimes
- 554
- January 4, 2018
inhibitor Kisqali New Approvals

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.